Antihistamine (H1, second-generation)
Pregnancy: Avoid — limited data. Loratadine or cetirizine preferred in pregnancy.
Acrivastine
Brand names: Benadryl Allergy Relief
Adult dose
Dose: 8 mg TDS
Route: Oral
Frequency: Three times daily
Max: 24 mg/day
Onset within 30 minutes — useful for prn allergy attacks.
Dose adjustments
Renal
Avoid if eGFR <50 ml/min — renally excreted.
Clinical pearls
- Faster onset (~30 min) than cetirizine or loratadine — useful for situational allergic symptoms (e.g., known cat exposure, hayfever flare).
- Three-times-daily dosing limits adherence vs once-daily second-generation alternatives — typically reserve for prn use.
- Available OTC as Benadryl Allergy Relief — note this differs from US Benadryl (diphenhydramine, first-generation).
- Less sedating than chlorphenamine but more so than fexofenadine — counsel against driving until effect known.
Contraindications
- Severe renal impairment (eGFR <50)
- Children under 12 years
- Hypersensitivity to triprolidine (parent compound)
Side effects
- Somnolence (low — second-generation, but more than cetirizine/loratadine)
- Headache
- Dry mouth
- Fatigue
Interactions
- Alcohol and other CNS depressants: additive sedation
- MAOIs: theoretical risk — caution
Reference: BNF 90; SmPC Benadryl Allergy Relief; BSACI Rhinitis Guideline 2017; NICE CKS Allergic Rhinitis. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020